Previous studies have shown specific adverse effects occurring during growth hormone replacement therapy in adults with GHD that are primarily related to sodium retention, including edema, arthralgia, myalgia, paresthesia, and carpal tunnel syndrome. This evidence concerns the gene GH1 and carpal tunnel syndrome.